Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
59.32
-1.76 (-2.88%)
Nov 17, 2026, 4:00 PM EST

SHA:688192 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
4,984801.14359.991.29-10.29
4,984801.14359.991.29-10.29
Revenue Growth
720.14%122.60%294.25%---62.95%
Cost of Revenue
46.0334.239.327.663.6512.93
Gross Profit
4,938766.91350.5883.63-3.65-2.65
Selling, General & Admin
689.01730.95598.78437.55128.4487.95
Research & Development
804.62855.61723.69801.15660.87583.67
Other Operating Expenses
37.49-0.850.67-0.27-0.390.1
Operating Expenses
1,5311,5871,3231,239788.9671.73
Operating Income
3,407-819.97-972.43-1,155-792.55-674.37
Interest Expense
-34.78-33.6-25.81-7.57-4.34-3.07
Interest & Investment Income
0.972.142.243.642.533.65
Currency Exchange Gain (Loss)
-1.01-1.01-2.45-1.4510.1-6.45
Other Non Operating Income (Expenses)
-6.442.282.99-0.04-0.03-0.08
EBT Excluding Unusual Items
3,366-850.16-995.46-1,161-784.3-680.32
Gain (Loss) on Sale of Investments
26.2325.3314.4522.5242.160.97
Gain (Loss) on Sale of Assets
0.130--0.010.02-
Other Unusual Items
57.8757.7141.3630.56.399.47
Pretax Income
3,450-767.13-939.65-1,108-735.74-669.88
Income Tax Expense
1.731.3900.10.26-
Earnings From Continuing Operations
3,449-768.52-939.66-1,108-736-669.88
Minority Interest in Earnings
5.954.4793.7---
Net Income
3,455-764.05-845.96-1,108-736-669.88
Net Income to Common
3,455-764.05-845.96-1,108-736-669.88
Net Income Growth
------
Shares Outstanding (Basic)
466447415407404360
Shares Outstanding (Diluted)
466447415407404360
Shares Change
7.35%7.75%1.83%0.70%12.29%0.07%
EPS (Basic)
7.42-1.71-2.04-2.72-1.82-1.86
EPS (Diluted)
7.42-1.71-2.04-2.72-1.82-1.86
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
3,415-758.79-788.1-1,000-677.15-501.26
Free Cash Flow Per Share
7.33-1.70-1.90-2.46-1.67-1.39
Gross Margin
99.08%95.73%97.41%91.61%--25.72%
Operating Margin
68.36%-102.35%-270.19%-1265.43%--6556.55%
Profit Margin
69.31%-95.37%-235.05%-1213.42%--6512.85%
Free Cash Flow Margin
68.51%-94.72%-218.98%-1095.44%--4873.51%
EBITDA
3,452-776.5-930.7-1,114-753.85-636.97
EBITDA Margin
69.26%-96.92%-258.60%---
D&A For EBITDA
44.7743.4741.7340.9438.737.4
EBIT
3,407-819.97-972.43-1,155-792.55-674.37
EBIT Margin
68.36%-102.35%-270.19%---
Revenue as Reported
4,984801.14359.991.29-10.29
Advertising Expenses
-210.92156.99-1.94-